Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Difference from Background: Limit of Detection01:05

Difference from Background: Limit of Detection

6.3K
The limit of detection (LOD) is the smallest amount of analyte that can be distinguished from the background noise. The LOD value corresponds to the concentration at which the analyte signal is three times larger than the standard deviation of the blank signal. Below this value, the analyte signal cannot be differentiated from the background noise. It is calculated by dividing the calibration slope by 3 times the standard deviation of the blank signals.
The LOD indicates the presence or absence...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Large Language Model-Based Classification of Case Report Abstracts: A Pilot Study on Interactions Between Radiotherapy and Systemic Therapies.

JCO clinical cancer informatics·2026
Same author

Linking neurological status to functional outcomes in spinal cord injury: a multi-class, task-specific approach.

BMC biomedical engineering·2026
Same author

Environmental antibiotics in wastewater disrupt zebrafish embryonic development via Wnt/β-catenin signaling: mechanistic insights and implications for risk assessment.

Ecotoxicology and environmental safety·2026
Same author

The KANSL1-ARL17A fusion gene generates oncogenic chKANSARL and F-circKA RNAs that synergistically drive lung cancer progression via a novel F-circKA/miR-6860/chKANSARL axis.

The Journal of biological chemistry·2026
Same author

Advancing mold identification in the routine laboratory, performance of smartphone-based imaging and a newly developed convolutional neural network.

Microbiology spectrum·2025
Same author

Conformal Prediction with Knowledge Graphs for Reliable Antimicrobial Resistance Detection with MALDI-TOF Mass Spectra.

Journal of computational biology : a journal of computational molecular cell biology·2025
Same journal

conMItion: an R package adjusting confounding factors for associations in multi-omics.

Bioinformatics (Oxford, England)·2026
Same journal

SpaMFG: a Spatial Multi-omics Integration Method based on Feature Grouping.

Bioinformatics (Oxford, England)·2026
Same journal

CSCN: Inference of Cell-Specific Causal Networks Using Single-Cell RNA-Seq Data.

Bioinformatics (Oxford, England)·2026
Same journal

Sparse CCA-Based Mediation Analysis with High-Dimensional Exposures and Mediators.

Bioinformatics (Oxford, England)·2026
Same journal

Enhancing Cross-Context Generalization in Drug Perturbation Prediction with a Multimodal Conditional Diffusion Framework.

Bioinformatics (Oxford, England)·2026
Same journal

Primer Design through Submodular Function Estimation.

Bioinformatics (Oxford, England)·2026
See all related articles

Related Experiment Video

Updated: Jun 22, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.5K

Biomarker identification by interpretable maximum mean discrepancy.

Michael F Adamer1,2, Sarah C Brüningk1,2,3, Dexiong Chen1,2,4

  • 1Department of Biosystems Science and Engineering, ETH Zurich, Basel 4056, Switzerland.

Bioinformatics (Oxford, England)
|June 28, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces SpInOpt-MMD, a novel method for identifying biomarkers in high-dimensional data. It effectively performs two-sample testing and feature selection simultaneously, outperforming existing methods in various applications.

More Related Videos

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K
Assisted Selection of Biomarkers by Linear Discriminant Analysis Effect Size LEfSe in Microbiome Data
04:57

Assisted Selection of Biomarkers by Linear Discriminant Analysis Effect Size LEfSe in Microbiome Data

Published on: May 16, 2022

15.7K

Related Experiment Videos

Last Updated: Jun 22, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.5K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K
Assisted Selection of Biomarkers by Linear Discriminant Analysis Effect Size LEfSe in Microbiome Data
04:57

Assisted Selection of Biomarkers by Linear Discriminant Analysis Effect Size LEfSe in Microbiome Data

Published on: May 16, 2022

15.7K

Area of Science:

  • Biomedical data analysis
  • Bioinformatics
  • Machine learning

Background:

  • Biomedical research often involves comparing paired sample groups (e.g., treated vs. control) using high-dimensional omics data.
  • Identifying discriminating features, or biomarkers, is crucial for understanding biological differences.
  • Current methods often separate two-sample testing and feature selection, limiting integrated analysis.

Purpose of the Study:

  • To develop a unified statistical framework for simultaneous two-sample testing and feature selection.
  • To introduce a sparse, interpretable, and optimized Maximum Mean Discrepancy (MMD) test (SpInOpt-MMD).
  • To demonstrate the versatility and effectiveness of SpInOpt-MMD across diverse data types.

Main Methods:

  • Developed the SpInOpt-MMD algorithm, integrating multivariate two-sample testing with sparse feature selection.
  • Applied SpInOpt-MMD to synthetic and real-world datasets, including images, gene expression, and text data.
  • Compared SpInOpt-MMD performance against established feature selection techniques like SHapley Additive exPlanations and univariate association analysis.

Main Results:

  • SpInOpt-MMD successfully performs simultaneous two-sample testing and feature selection.
  • The method demonstrates effectiveness in identifying relevant features, even with small sample sizes.
  • SpInOpt-MMD outperformed alternative feature selection methods in several experimental comparisons.

Conclusions:

  • SpInOpt-MMD offers a powerful and versatile approach for biomarker discovery in high-dimensional biomedical data.
  • The integrated method provides both statistical significance testing and interpretable feature identification.
  • The developed method enhances the analysis of complex biological datasets, particularly in scenarios with limited samples.